Evaluation of early left-sided cardiac reverse remodeling under combined therapy of sacubitril-valsartan and spironolactone compared with angiotensin-converting enzyme inhibitors and spironolactone

We aimed to compare therapies of sacubitril/valsartan + spironolactone (S/V + S) with angiotensin-converting enzyme inhibitors + spironolactone (ACEI + S) on the left-sided cardiac reverse remodeling (L-CRR). The second objective was to analyze the usefulness of GLS and LVEF in response to therapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Sacharczuk, Wioletta, Dankowski, Rafał, Ożegowski, Stefan, Rojna, Maciej, Szyszka, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106719/
https://www.ncbi.nlm.nih.gov/pubmed/37077749
http://dx.doi.org/10.3389/fcvm.2023.1103688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106719/
https://www.ncbi.nlm.nih.gov/pubmed/37077749
http://dx.doi.org/10.3389/fcvm.2023.1103688

Ejemplares similares